万孚生物：预计2025年净利润同比下降87.71%-91.81%

Core Viewpoint - The company expects a significant decline in net profit for the fiscal year 2025, projecting a range of 46 million to 69 million yuan, which represents a year-on-year decrease of 87.71% to 91.81% [1] Group 1: Financial Performance - The main business revenue has declined year-on-year, primarily due to a drop in domestic income [1] - The adjustment in the value-added tax rate has impacted revenue negatively [1] - Hospital business has been affected by medical industry policies, leading to pressure on both volume and pricing [1] Group 2: Business Segments - Despite the challenges in domestic operations, overseas business development remains robust, providing crucial support for the company's overall sustainable growth [1]